These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31971004)

  • 1. Request for an Andexxa Value Analysis.
    Yin E; McConnell KJ
    Ann Pharmacother; 2020 Jul; 54(7):715-717. PubMed ID: 31971004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andexanet Alfa (Andexxa) Formulary Review.
    Beik N; Reddy P; Sylvester KW; Connell NT; Giugliano RP; Piazza G; Connors JM
    Crit Pathw Cardiol; 2019 Jun; 18(2):66-71. PubMed ID: 31094731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Andexanet Alfa: First Global Approval.
    Heo YA
    Drugs; 2018 Jul; 78(10):1049-1055. PubMed ID: 29926311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andexxa--an antidote for apixaban and rivaroxaban.
    Med Lett Drugs Ther; 2018 Jun; 60(1549):99-101. PubMed ID: 29913471
    [No Abstract]   [Full Text] [Related]  

  • 5. Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence.
    Abdulrehman J; Eikelboom JW; Siegal DM
    Future Cardiol; 2019 Nov; 15(6):395-404. PubMed ID: 31668083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).
    Rogers KC; Finks SW
    Am J Med; 2019 Jan; 132(1):38-41. PubMed ID: 30053385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety and efficacy of andexanet alfa in animal models.
    Lu G; Hollenbach SJ; Baker DC; Tan S; Hutchaleelaha A; Curnutte JT; Conley PB
    J Thromb Haemost; 2017 Sep; 15(9):1747-1756. PubMed ID: 28682477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
    Escolar G; Diaz-Ricart M; Arellano-Rodrigo E
    Drugs Today (Barc); 2017 May; 53(5):271-282. PubMed ID: 28650000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
    Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
    N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation.
    Ghadimi K; Dombrowski KE; Levy JH; Welsby IJ
    Expert Rev Hematol; 2016; 9(2):115-22. PubMed ID: 26686866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Andexanet alfa for the treatment of hemorrhage.
    Cervi A; Crowther M
    Expert Rev Hematol; 2018 Nov; 11(11):847-855. PubMed ID: 30296870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis.
    Nederpelt CJ; Naar L; Krijnen P; le Cessie S; Kaafarani HMA; Huisman MV; Velmahos GC; Schipper IB
    Crit Care Med; 2021 Oct; 49(10):e1025-e1036. PubMed ID: 33967205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andexanet: Effectively Reversing Anticoagulation.
    Lippi G; Sanchis-Gomar F; Favaloro EJ
    Trends Pharmacol Sci; 2016 Jun; 37(6):413-414. PubMed ID: 27048885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.
    Grottke O; Braunschweig T; Rossaint R; Akman N; Leeds JM; Conley PB; Honickel M
    Br J Anaesth; 2019 Aug; 123(2):186-195. PubMed ID: 31202564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
    Desai NR; Cornutt D
    Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent.
    Powell J; Taylor J; Garland SG
    Ann Pharmacother; 2019 Sep; 53(9):940-946. PubMed ID: 30813754
    [No Abstract]   [Full Text] [Related]  

  • 17. Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.
    Lu G; Pine P; Leeds JM; DeGuzman F; Pratikhya P; Lin J; Malinowski J; Hollenbach SJ; Curnutte JT; Conley PB
    PLoS One; 2018; 13(3):e0195122. PubMed ID: 29590221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of andexanet alfa in the reversal of anticoagulant effects?
    Sewell JH; Williams L; McKnight E; Nguyen A; Sarac M
    JAAPA; 2021 Jan; 34(1):8-9. PubMed ID: 33332828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values.
    Siddiqui F; Tafur A; Ramacciotti LS; Jeske W; Hoppensteadt D; Ramacciotti E; Iqbal O; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619863493. PubMed ID: 31298056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage.
    Frontera JA; Bhatt P; Lalchan R; Yaghi S; Ahuja T; Papadopoulos J; Joset D
    J Thromb Thrombolysis; 2020 Jan; 49(1):121-131. PubMed ID: 31664662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.